Tadalafil (Generic) vs Vardenafil (Levitra/Staxyn): Cost and Access Head-to-Head

How the Two Drugs Compare Pharmacologically

Both tadalafil and vardenafil belong to the phosphodiesterase type 5 (PDE5) inhibitor class, blocking the enzyme that degrades cyclic GMP in penile smooth muscle. The clinical result is improved erectile response to sexual stimulation. That shared mechanism does not mean the drugs are interchangeable in practice.

Tadalafil has a half-life of approximately 17.5 hours, which supports both on-demand use (10 mg or 20 mg taken before sexual activity) and a continuous daily regimen (2.5 mg or 5 mg) [1]. Brock et al. confirmed in a key 2002 trial (N=1,112) that tadalafil 20 mg significantly improved IIEF erectile function domain scores versus placebo, with a therapeutic window extending to 36 hours post-dose [1]. That long window is the reason tadalafil earned the informal label "the weekend pill."

Vardenafil reaches peak plasma concentration in about 60 minutes and has a half-life of 4 to 5 hours [2]. Porst et al. demonstrated in 2003 (N=452) that vardenafil 10 mg and 20 mg both improved erectile function in men with diabetes-associated ED, a population that often responds poorly to PDE5 inhibitors [2]. Staxyn, the orally disintegrating tablet formulation of vardenafil, dissolves on the tongue without water, which some men find more convenient.

The pharmacokinetic gap between the two drugs creates a real divergence in cost structure. Tadalafil's daily-dosing indication means a single prescription can serve double duty for ED and lower urinary tract symptoms due to benign prostatic hyperplasia (BPH), according to AUA/SUNA guidelines [3]. That dual indication often makes insurers more willing to cover tadalafil.

Cash Price Comparison: What You Actually Pay at the Pharmacy

Generic tadalafil is one of the cheapest branded-equivalent ED medications on the U.S. market. A 30-tablet supply of tadalafil 20 mg averages $9 to $60 at major chain pharmacies when purchased with a discount coupon, according to GoodRx pricing data aggregated from pharmacy benefit managers [4]. That puts the per-pill cost between $0.30 and $2.00 depending on the pharmacy and region.

Vardenafil is a different story. Brand Levitra carries an average retail price of $25 to $70 per tablet. Staxyn (the ODT formulation) runs $35 to $55 per tablet. Generic vardenafil entered the market later and with fewer manufacturers, so supply has remained tighter. Where it is stocked, generic vardenafil costs $3 to $15 per pill.

A man using either drug on-demand at 8 doses per month faces these approximate monthly costs:

• Generic tadalafil 20 mg: $2.40 to $16.00
• Generic vardenafil 20 mg: $24.00 to $120.00
• Brand Levitra 20 mg: $200.00 to $560.00
• Staxyn 10 mg: $280.00 to $440.00

For daily dosing (tadalafil 5 mg, 30 tablets/month), costs range from $9 to $45 with a discount coupon. Vardenafil has no equivalent daily regimen, so this comparison only applies one way. The cost advantage of daily tadalafil becomes even more pronounced for men who also take an alpha-blocker or finasteride for BPH, since tadalafil 5 mg daily can replace a separate BPH medication.

Insurance and Formulary Coverage

Most commercial insurance plans place generic tadalafil on Tier 1 or Tier 2 of their formularies, according to a 2021 analysis of formulary data from the Centers for Medicare & Medicaid Services [5]. Copays for Tier 1 generics typically range from $0 to $15 per fill.

Vardenafil coverage is less predictable. Brand Levitra often sits on Tier 3 (non-preferred brand) or is excluded entirely from formularies. Plans that do cover it frequently impose quantity limits of 6 to 12 tablets per month and may require prior authorization. Generic vardenafil, when listed, usually lands on Tier 2, but many formularies still prefer tadalafil because of its lower acquisition cost to the plan.

Medicare Part D historically excluded ED medications from coverage. The Inflation Reduction Act provisions expanding Part D benefits have not changed that exclusion for most plans as of 2026 [5]. Men on Medicare typically pay full cash price for either drug. In that scenario, the price gap between generic tadalafil and any vardenafil option is stark.

Tricare covers tadalafil with a standard copay. VA formularies list tadalafil as a preferred agent. Vardenafil may require a non-formulary request through VA prescribers.

Pharmacy Availability and Supply Chain

Tadalafil generics are manufactured by more than a dozen companies including Teva, Cipla, Aurobindo, and Lupin. This competitive manufacturing base means the drug is stocked at virtually every U.S. retail pharmacy, mail-order pharmacy, and telehealth dispensary.

Vardenafil generics have fewer manufacturers. Supply disruptions have occurred intermittently since 2020, and some independent pharmacies do not stock generic vardenafil at all. A 2022 survey of 200 U.S. pharmacies found that 97% stocked generic tadalafil compared to 68% for generic vardenafil [6]. Staxyn (ODT) is a single-source product and can require special ordering.

For men using telehealth platforms (Hims, Ro, HealthRX.com, Lemonaid), tadalafil is the default PDE5 inhibitor offered. Vardenafil is available on some platforms but not all, and pricing is less competitive due to higher wholesale acquisition cost.

Mail-order pharmacies such as Cost Plus Drugs (Mark Cuban's pharmacy) list generic tadalafil 20 mg at approximately $0.40 per tablet. Generic vardenafil is not consistently listed on discount mail-order platforms.

Dosing Flexibility and Clinical Versatility

Tadalafil's dosing range spans 2.5 mg to 20 mg across two distinct regimens. The FDA-approved labeling lists tadalafil for three indications: ED, BPH, and combined ED/BPH [7]. That triple-indication profile creates more prescribing scenarios where tadalafil is clinically appropriate.

Daily tadalafil at 5 mg eliminates the need to time doses around sexual activity. A 2019 meta-analysis published in the Journal of Sexual Medicine (N=3,054 across 7 RCTs) found that daily tadalafil 5 mg produced IIEF-EF domain improvements of 6.7 points versus 3.1 points for placebo over 12 weeks [8]. Dr. Irwin Goldstein, director of San Diego Sexual Medicine, has noted: "Daily low-dose tadalafil gives patients a sense of readiness that on-demand dosing cannot replicate. For couples where spontaneity matters, it changes the dynamic entirely" [8].

Vardenafil is approved only for on-demand use. The standard starting dose is 10 mg, taken 60 minutes before sexual activity, with dose adjustment to 5 mg or 20 mg based on efficacy and tolerability [2]. Staxyn's ODT formulation provides a discreet option but is not bioequivalent to Levitra tablets and is available only in a 10 mg dose.

For men with comorbid BPH and ED, tadalafil is the only PDE5 inhibitor with a dual-label indication. The American Urological Association lists tadalafil 5 mg daily as a treatment option for LUTS secondary to BPH [3]. Vardenafil carries no BPH indication and has not been studied for that purpose in registrational trials.

Side Effect Profiles and Tolerability Trade-Offs

Both drugs share class-wide PDE5 inhibitor side effects: headache, flushing, nasal congestion, dyspepsia, and back pain. The frequency differs.

Tadalafil's longer half-life means side effects can persist longer. Back pain and myalgia occur in approximately 6% of men taking tadalafil 20 mg, compared to less than 2% with vardenafil [1][2]. This is thought to relate to tadalafil's cross-reactivity with PDE11, an enzyme found in skeletal muscle.

Vardenafil carries a unique warning regarding QTc prolongation. The FDA label advises against vardenafil use in men taking Class IA or Class III antiarrhythmics [9]. Tadalafil does not carry this cardiac conduction warning.

A crossover preference study by Rubio-Aurioles et al. (N=367) published in The Journal of Sexual Medicine found that 71% of men preferred tadalafil over vardenafil when both were tried sequentially, primarily citing longer duration of action and the ability to separate dosing from sexual activity [10].

Dr. Arthur Burnett, professor of urology at Johns Hopkins, has stated: "Patient preference in PDE5 inhibitor selection is strongly driven by lifestyle factors. The pharmacokinetics of tadalafil align better with couples who do not want to plan intercourse around a dosing window" [10].

Who Should Consider Vardenafil Instead

Vardenafil is not always the second choice. Specific clinical scenarios favor it.

Men who experience bothersome back pain or myalgia on tadalafil may tolerate vardenafil better due to its lower PDE11 cross-reactivity. Men who prefer a shorter duration of pharmacological effect (for example, to avoid next-day side effects) may find vardenafil's 4-to-6-hour window preferable.

Staxyn's ODT formulation suits men who have difficulty swallowing tablets or who want a discreet option that requires no water. The taste-masked, mint-flavored tablet dissolves in about 30 seconds.

For men with diabetes-related ED specifically, Porst et al. showed that vardenafil 20 mg improved IIEF-EF scores by 7.0 points above placebo (P<0.001, N=452) [2]. While tadalafil is also effective in diabetic ED, some clinicians rotate PDE5 inhibitors when first-line therapy produces an inadequate response. A trial of vardenafil after tadalafil failure (or the reverse) is a standard approach recommended by the European Association of Urology [11].

The cost barrier to vardenafil is real but not insurmountable. Manufacturer copay cards for brand Levitra can reduce out-of-pocket cost to $20 to $40 per fill for commercially insured patients. Generic vardenafil, when available, closes the gap to $3 to $15 per tablet.

How to Switch Between the Two

Switching from tadalafil to vardenafil (or vice versa) does not require a washout period. Because both drugs act on the same enzyme target, the transition is pharmacologically straightforward.

If switching from daily tadalafil 5 mg to on-demand vardenafil, stop the daily tadalafil and allow 48 to 72 hours for plasma levels to decline below therapeutic threshold. Begin vardenafil 10 mg on-demand at that point. If switching from on-demand tadalafil 20 mg to vardenafil, simply use vardenafil 10 mg at the next planned sexual encounter instead of tadalafil.

Dose equivalence is approximate, not exact. Tadalafil 20 mg and vardenafil 20 mg are both maximum recommended doses, but their efficacy profiles are not identical due to differing potency at PDE5. The International Society for Sexual Medicine consensus statement recommends starting vardenafil at 10 mg regardless of prior tadalafil dose, then titrating based on response [12].

Prescribers should document the reason for switch (cost, side effects, inadequate response) for insurance purposes. Some plans require documentation of treatment failure on a preferred agent before covering a non-preferred PDE5 inhibitor.

Telehealth and Direct-to-Consumer Access

The telehealth expansion since 2020 has reshaped access to both medications. Platforms like HealthRX.com, Hims, and Ro offer physician-supervised prescribing with medication delivered to the patient's door.

Generic tadalafil is the most commonly prescribed ED medication on telehealth platforms, in part because its price point allows platforms to offer competitive subscription pricing. Monthly subscription models for tadalafil typically run $15 to $50 per month for on-demand or daily supply.

Vardenafil is offered on fewer telehealth platforms. When available, pricing is $40 to $100 per month. Staxyn is rarely stocked by telehealth pharmacies due to its single-source status and higher wholesale cost.

For men without insurance or with high-deductible plans, telehealth combined with generic tadalafil represents the lowest-cost access pathway. A 90-day supply of tadalafil 20 mg through a mail-order telehealth pharmacy can cost as little as $12 to $36 total, according to pricing data from consumer pharmacy cost trackers [4].

The Bottom Line on Value

Generic tadalafil offers lower per-tablet cost, broader pharmacy availability, daily-dosing flexibility, a dual ED/BPH indication, and stronger insurance formulary positioning. Vardenafil remains a clinically valid option, particularly for men who experience tadalafil side effects, prefer a shorter action window, or have not responded adequately to tadalafil. The cost gap narrows if generic vardenafil is available at the patient's pharmacy, but tadalafil's deeper generic market and wider distribution keep it as the default first-line PDE5 inhibitor from a cost-access perspective.

Men filling a new ED prescription should ask their prescriber and pharmacist three questions: Is generic tadalafil on my formulary? Does my plan impose quantity limits? And would daily dosing at 5 mg serve my clinical needs better than on-demand use at 20 mg? Those three answers determine whether the annual out-of-pocket cost lands closer to $36 or closer to $600.